Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Philogen S.p.A.
Sponsor:
Information provided by (Responsible Party):
Philogen S.p.A.
ClinicalTrials.gov Identifier:
NCT01134250
First received: May 25, 2010
Last updated: October 20, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2016
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)